相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lipid nanocarriers for microRNA delivery
Marcel Scheideler et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2020)
Identification and evolutionary analysis of polycistronic miRNA clusters in domesticated and wild wheat
Amit Kumar Singh et al.
GENOMICS (2020)
Communication in tiny packages: Exosomes as means of tumor-stroma communication
Juliane Dassler-Plenker et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
The Potential for microRNA Therapeutics and Clinical Research
Johora Hanna et al.
FRONTIERS IN GENETICS (2019)
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment
Antonio Giovanni Solimando et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma
Hiroshi Handa et al.
CANCERS (2019)
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes
Maria Antonia Frassanito et al.
JOURNAL OF PATHOLOGY (2019)
Induction of multiple myeloma bone marrow stromal cell apoptosis by inhibiting extracellular vesicle miR-10a secretion
Tomohiro Umezu et al.
BLOOD ADVANCES (2019)
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells
C. Botta et al.
LEUKEMIA (2018)
The AGO proteins: an overview
Saife Niaz
BIOLOGICAL CHEMISTRY (2018)
Treating cancer with microRNA replacement therapy: A literature review
Nayer Hosseinahli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Anti-miRNA oligonucleotides: A comprehensive guide for design
Joana Filipa Lima et al.
RNA BIOLOGY (2018)
The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma (Review)
Bingying Zhu et al.
ONCOLOGY LETTERS (2018)
The diagnostic and prognostic value of plasma microRNA-125b-5p in patients with multiple myeloma
Yanxia Jiang et al.
ONCOLOGY LETTERS (2018)
The expression and role of miR-181a in multiple myeloma
Ruili Yuan et al.
MEDICINE (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Response to An innovative mesothelioma treatment based on mir-16 mimic loaded EGFR targeted minicells (TargomiRs)
Nico van Zandwijk et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
Combination therapy to checkmate Glioblastoma: clinical challenges and advances
Debarati Ghosh et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Integrative analysis of signaling pathways and diseases associated with the miR-106b/25 cluster and their function study in berberine-induced multiple myeloma cells
Chunming Gu et al.
FUNCTIONAL & INTEGRATIVE GENOMICS (2017)
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
Muhammad S. Beg et al.
INVESTIGATIONAL NEW DRUGS (2017)
The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma
S. Manier et al.
LEUKEMIA (2017)
Response commentary: exosomes vs microvesicles in hematological malignancies
T. L. Whiteside et al.
LEUKEMIA (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell
Alboukadel Kassambara et al.
NUCLEIC ACIDS RESEARCH (2017)
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment
Mayra Rachele Zarone et al.
SCIENTIFIC REPORTS (2017)
Exosomes and other extracellular vesicles-mediated microRNA delivery for cancer therapy
Giuliana Di Rocco et al.
TRANSLATIONAL CANCER RESEARCH (2017)
Nanocarriers for microRNA delivery in cancer medicine
I. Fernandez-Pineiro et al.
BIOTECHNOLOGY ADVANCES (2017)
Prognostic role of circulating exosomal miRNAs in multiple myeloma
Salomon Manier et al.
BLOOD (2017)
miRNA nanotherapeutics for cancer
Aditya Ganju et al.
DRUG DISCOVERY TODAY (2017)
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
Annamaria Gulla et al.
CLINICAL CANCER RESEARCH (2016)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Effect of surface properties on liposomal siRNA delivery
Yuqiong Xia et al.
BIOMATERIALS (2016)
Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity
Kim De Veirman et al.
CANCER LETTERS (2016)
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
Alexander A. Svoronos et al.
CANCER RESEARCH (2016)
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma
Nicola Amodio et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer
Glen Reid et al.
EPIGENOMICS (2016)
Microenvironment drug resistance in multiple myeloma: emerging new players
Lucia Di Marzo et al.
ONCOTARGET (2016)
Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma
Li Zhang et al.
ONCOTARGET (2016)
MiR-10b decreases sensitivity of glioblastoma cells to radiation by targeting AKT
Limin Zhen et al.
JOURNAL OF BIOLOGICAL RESEARCH-THESSALONIKI (2016)
MRX34, a liposomal miR-34 mimic, in patients with advanced solid tumors: Final dose-escalation results from a first-in-human phase I trial of microRNA therapy.
David S. Hong et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Nanocarrier-based co-delivery of small molecules and siRNA/miRNA for treatment of cancer
Deepak Chitkara et al.
THERAPEUTIC DELIVERY (2016)
miRNAs in pancreatic cancer: Therapeutic potential, delivery challenges and strategies
Deepak Chitkara et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Yunching Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
Jian-Jun Zhao et al.
CANCER RESEARCH (2015)
Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer
Tzu-Yin Wang et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Simultaneous Drug and Gene Delivery from the Biodegradable Poly(ε-caprolactone) Nanofibers for the Treatment of Liver Cancer
Hui-Lian Che et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2015)
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
E. Morelli et al.
LEUKEMIA (2015)
MicroRNA-34c targets TGFB-induced factor homeobox 2, represses cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma
Yan Wang et al.
ONCOLOGY LETTERS (2015)
Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
Donato Cosco et al.
SCIENTIFIC REPORTS (2015)
Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
Lin Kang et al.
ACTA PHARMACEUTICA SINICA B (2015)
Long chain microRNA conjugates in calcium phosphate nanoparticles for efficient formulation and delivery
Hyosook Jung et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
The complexity of miRNA-mediated repression
A. Wilczynska et al.
CELL DEATH AND DIFFERENTIATION (2015)
MiR-29b replacement inhibits proteasomes and disrupts aggresome plus autophagosome formation to enhance the antimyeloma benefit of bortezomib
S. Jagannathan et al.
LEUKEMIA (2015)
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
Nicola Amodio et al.
Oncotarget (2015)
Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages
Giuseppina Turturici et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer
Masaki Mori et al.
CELL (2014)
Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation
Julie Devalliere et al.
FASEB JOURNAL (2014)
A p53-Dependent Tumor Suppressor Network Is Induced by Selective miR-125a-5p Inhibition in Multiple Myeloma Cells
Marzia Leotta et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances
Nishant S. Gandhi et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression
Sanjun Shi et al.
JOURNAL OF CONTROLLED RELEASE (2014)
MicroRNA theragnostics for the clinical management of multiple myeloma
N. Ahmad et al.
LEUKEMIA (2014)
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy
Carla L. Esposito et al.
MOLECULAR THERAPY (2014)
被撤回的出版物: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (Retracted article. See vol. 582, pg. 134, 2020)
Jing Y. Krzeszinski et al.
NATURE (2014)
Regulation of microRNA biogenesis
Minju Ha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras
Zhumei Shi et al.
NEURO-ONCOLOGY (2014)
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
Maria Teresa Di Martino et al.
PLOS ONE (2014)
Endogenous RNAs Modulate MicroRNA Sorting to Exosomes and Transfer to Acceptor Cells
Mario Leonardo Squadrito et al.
CELL REPORTS (2014)
Mir-34: A New Weapon Against Cancer?
Gabriella Misso et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers
Raisa Krutilina et al.
BREAST CANCER RESEARCH (2014)
Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth
Mark Katakowski et al.
CANCER LETTERS (2013)
miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF
Chun-Yan Sun et al.
CARCINOGENESIS (2013)
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
Emanuela Leone et al.
CLINICAL CANCER RESEARCH (2013)
Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics
Muthunarayanan Muthiah et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease
Marco Rossi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression
Aldo M. Roccaro et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations
Xinmei Wang et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Progress in microRNA delivery
Yu Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
Yun Wu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
MicroRNAs in the Pathobiology of Multiple Myeloma
Marta Lionetti et al.
CURRENT CANCER DRUG TARGETS (2012)
Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
P. Tagliaferri et al.
CURRENT CANCER DRUG TARGETS (2012)
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Marilena V. Iorio et al.
EMBO MOLECULAR MEDICINE (2012)
Sequence-Dependent Synergistic Inhibition of Human Glioma Cell Lines by Combined Temozolomide and miR-21 Inhibitor Gene Therapy
Xiaomin Qian et al.
MOLECULAR PHARMACEUTICS (2012)
The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC
Marc R. Fabian et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer
M. V. Geraldo et al.
ONCOGENE (2012)
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
Imran A. Babar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N. Amodio et al.
CELL DEATH & DISEASE (2012)
Horizontal transfer of RNAs: exosomes as mediators of intercellular communication
Saraswathi Ramachandran et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
Pathogenesis of Myeloma
Kenneth C. Anderson et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1
Yi-Kun Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma
Lijuan Chen et al.
CANCER LETTERS (2011)
MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
Ahmed Fawzy Ibrahim et al.
CANCER RESEARCH (2011)
Developing therapeutic microRNAs for cancer
A. G. Bader et al.
GENE THERAPY (2011)
MicroRNA Delivery by Cationic Lipoplexes for Lung Cancer Therapy
Yun Wu et al.
MOLECULAR PHARMACEUTICS (2011)
Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation
Xudong Wang et al.
LEUKEMIA & LYMPHOMA (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
MicroRNA Profiles of Drug-Resistant Myeloma Cell Lines
Reinhold Munker et al.
ACTA HAEMATOLOGICA (2010)
Epigenetic inactivation of the miR-34a in hematological malignancies
C. S. Chim et al.
CARCINOGENESIS (2010)
The widespread regulation of microRNA biogenesis, function and decay
Jacek Krol et al.
NATURE REVIEWS GENETICS (2010)
Structure and activity of putative intronic miRNA promoters
Alex Mas Monteys et al.
RNA (2010)
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
Marta Lionetti et al.
BLOOD (2009)
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
Aldo M. Roccaro et al.
BLOOD (2009)
SnapShot: MicroRNAs in Cancer
Riccardo Spizzo et al.
CELL (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer
Fabio Petrocca et al.
CANCER CELL (2008)
Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer
Shengming Dai et al.
MOLECULAR THERAPY (2008)
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Flavia Pichiorri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
let-7 microRNAs in development, stem cells and cancer
Ingo Buessing et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Interleukin-6-dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer
Dennis Loeffler et al.
BLOOD (2007)
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
C. Welch et al.
ONCOGENE (2007)
A microRNA component of the p53 tumour suppressor network
Lin He et al.
NATURE (2007)
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes:: results of thefirst phase I clinical trial
B Escudier et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
MA Morse et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Micrornas: Small RNAs with a big role in gene regulation
L He et al.
NATURE REVIEWS GENETICS (2004)
Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: Methods and evidence for nonviral mRNA gene delivery to the central nervous system
DM Anderson et al.
HUMAN GENE THERAPY (2003)
MicroRNA maturation: stepwise processing and subcellular localization
Y Lee et al.
EMBO JOURNAL (2002)
Cationic lipid-based delivery system for systemic cancer gene therapy
K Anwer et al.
CANCER GENE THERAPY (2000)
分享论文
